Bioxyne Limited (ASX:BXN)

2.5¢

right-arrow Created with Sketch. 0.001 (4.17%)
MCAP $16.00M
Last trade 11.27am 21/01/2022 20mins delayed

Latest Announcements

30/11/2021BXNBioxyne Limited
04/11/2021 Price SensitivePSBXNBioxyne Limited
04/11/2021 Price SensitivePSBXNBioxyne Limited
29/10/2021BXNBioxyne Limited
29/10/2021BXNBioxyne Limited
29/10/2021 Price SensitivePSBXNBioxyne Limited
28/10/2021 Price SensitivePSBXNBioxyne Limited
27/10/2021 Price SensitivePSBXNBioxyne Limited
953
MCap

Company Overview

Bioxyne Limited is an Australia-based bio-technology company. The Company is engaged in the development of, manufacture, marketing and distribution of consumer dietary supplements based on the probiotic strain of Lactobacillus Fermentum PCC. The Company operates through two segments wholesale sales and direct sales. The Company manufactures, market, supplies and distributes its probiotic strain for over the counter dietary supplement products for the food, health, pharmaceutical and agricultural businesses. The Company is focusing on developing a range of functional food and beauty products.

BXN in the news

Science research company Bioxyne, has had a positive September quarter, reporting strong…

Search Previous Announcements